Author

Juan Esteban Valencia

Observed names: J.E. Valencia, Juan E. Valencia, Juan Valencia, Valencia, J. E.

Observed institutions: Medtronic (United States), Bristol-Myers Squibb (United States), Medtronic (India), Miami Foundation, HistoryMiami, Bristol-Myers Squibb (United Kingdom), Universidad CES, Clínica Medellín SAS

ORCID: 0009-0001-7016-8031

Observed ORCID: 0009-0001-7016-8031

OpenAlex ID: A5113794017

The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence

2009 · Maria Teresa Valenzuela, Rosalyn O'Loughlin, et al. · Revista Panamericana de Salud Pública · 81

PDF

Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis

2008 · Anushua Sinha, Dagna Constenla, et al. · Revista Panamericana de Salud Pública · 53

PDF

Socio-demographic and clinical characteristics of type 1 diabetes patients associated with emergency room visits and hospitalizations in Mexico

2018 · Svetlana V. Doubova, Aldo Ferreira-Hermosillo, et al. · BMC Health Services Research · 21

PDF

Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia

2016 · Ana Maria Gomez, Rafael Alfonso-Cristancho, et al. · Endocrinología y Nutrición · 17

Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia

2016 · Ana Maria Gomez, Rafael Alfonso-Cristancho, et al. · Endocrinología y Nutrición (English Edition) · 15

Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean

2009 · Dagna Constenla, Anushua Sinha, et al. · Revista Panamericana de Salud Pública · 12

Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

2019 · Svetlana V. Doubova, Stephane Roze, et al. · Cost Effectiveness and Resource Allocation · 9

PDF

Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA study

2021 · Lucas Higuera, Reece Holbrook, et al. · Journal of Medical Economics · 8

Multidisciplinary Heart Failure Care Program: An Experience From Colombia

2022 · Clara Saldarriaga, Catalina Gallego, et al. · Current Problems in Cardiology · 5

Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion in Argentina: An Economic Analysis

2022 · Pedro Lylyk, Juan Cirio, et al. · Journal of Stroke and Cerebrovascular Diseases · 5

Economic evaluation of type 2 diabetes treatment with saxagliptin in Colombia

2012 · Jorge F. Elgart, Lorena Gonzalez, et al. · Medwave · 3

Costo-efectividad del tratamiento de denervación renal vs. mejor tratamiento médico estándar disponible en el control de la hipertensión resistente en Colombia

2014 · Juan E. Valencia, John J. Orozco · Revista Colombiana de Cardiología · 2

PDF

Cost Utility Analysis Of Sacral Neuromodulation Versus Botox A In The Treatment Of Overactive Bladder In Colombia

2014 · JC Castaño, A. Lopera, et al. · Value in Health · 2

Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in Colombia

2013 · A. Gomez, R. Alfonso-Cristancho, et al. · Value in Health · 2

Cost-effectiveness analysis of catheter based renal denervation (RDN) for resistant arterial hypertension in Colombia

2013 · J.E. Valencia, O.D. Diaz-Sotelo, et al. · Value in Health · 2

Pmd22 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy With Stent Retrievers After Thrombolysis in Ischemic-stroke With Large Vessel Occlusion in the Chilean Public Sector.

2020 · R. Lenz Alcayaga, D. Paredes, et al. · Value in Health · 1

PDF

Adaptation to Colombia and Venezuela of the economic model Dasatinib first-line treatment of chronic myeloid leukemia, developed by the York Health Economics Consortium

2012 · Juan E. Valencia, John J. Orozco · Medwave · 1

PMS9 What is the Value of the New Kid on the Block?: tocilizumab versus Abatacept for Rheumatoid Arthritis in Colombia

2011 · R. Alfonso-Cristancho, E.C. Aiello, et al. · Value in Health · 1

Evaluación económica del dasatinib en el tratamiento de la leucemia mieloide crónica en pacientes resistentes al imatinib en Chile

2011 · John Orozco, Juan Valencia, et al. · Medwave · 1

PDF

Pmd26 a Cost-effectiveness and Sensitivity Analysis of Metal Needles Compared With Plastic Fistula Cannulas for Hemodialysis Patients in Mexico, Considering Needle-induced Injury Requiring Intervention

2020 · K. Jones, S. Fajardo Gallegos, et al. · Value in Health

Pnd23 Cost-effectiveness Analysis of Deep Brain Stimulation, Compared to Vagus Nerve Stimulation and Antiepileptic Drugs for Refractory Epilepsy in Colombia

2020 · J. Tellez, J. Arcos, et al. · Value in Health

Pnd27 Cost-utility of Mechanical Thrombectomy After Thrombolysis in Ischemic-stroke in the Chilean Public Sector.

2020 · D. Paredes, R. Lenz Alcayaga, et al. · Value in Health

Mt3 Icd Therapy for Sudden Cardiac Arrest Prevention Is Potentially Cost-effective in the 1.5 Primary Prevention Population in Colombia: an Economic Evaluation of the Improved Sca Study

2019 · L. Higuera, R. Holbrook, et al. · Value in Health Regional Issues

Cost Effectiveness Of Drug Eluting Balloon Versus Percutaneous Transluminal Balloon Angioplasty, Bare Metal Stent And Drug Eluting Stent In The Treatment Of Peripheral Arterial Disease In Lower Limbs Colombia

2014 · J.J. Orozco, J.E. Valencia, et al. · Value in Health

Interactive Probabilistic Cost Model For Comparison Remote Versus In-Office Monitoring For Cardiac Rhythm Device Patients, In A Specialized Cardiovascular Clinic In Colombia

2014 · C. Saldarriaga, N. Gonzalez, et al. · Value in Health

Works count: 38

Citation count: 241

H-index: 8

I10-index: 6